Connect with us

Health

New drug treatment could soon benefit people with rheumatoid arthritis – News-Medical.Net

People with Rheumatoid Arthritis (RA) could soon benefit from a new drug treatment that not only suppresses inflammation but also significantly reduces patient…

Published

on

Reviewed by Emily Henderson, B.Sc.Nov 25 2020
People with Rheumatoid Arthritis (RA) could soon benefit from a new drug treatment that not only suppresses inflammation but also significantly reduces patient reported pain scores. Otilimab is a monoclonal antibody, biologic drug, which targets and suppresses the inflammatory cytokine GM-CSF.
In a multicenter, dose-ranging trial, led by Professor Chris Buckley at the Universities of Oxford and Birmingham, and sponsored by the Pharmaceutical company…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending